OA11944A - 1-Trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives. - Google Patents

1-Trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives. Download PDF

Info

Publication number: OA11944A
Authority: OA; OAPI
Prior art keywords: disorder; disorders; syndrome; compound; alkyl
Prior art date: 1999-05-21

Application number

OA1200100302A

Other languages

English (en)

Inventor

Ronald Scott Obach

Douglas Alan Scully

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-21

Filing date

2000-04-24

Publication date

2006-04-12

2000-04-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2006-04-12 Publication of OA11944A publication Critical patent/OA11944A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Otolaryngology (AREA)

OA1200100302A 1999-05-21 2000-04-24 1-Trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives. OA11944A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13539999P	1999-05-21	1999-05-21

Publications (1)

Publication Number	Publication Date
OA11944A true OA11944A (en)	2006-04-12

Family

ID=22467939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200100302A OA11944A (en)	1999-05-21	2000-04-24	1-Trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives.

Country Status (49)

Country	Link
US (1)	US6239147B1 (pt)
EP (1)	EP1178984B1 (pt)
JP (1)	JP3802762B2 (pt)
KR (1)	KR100453301B1 (pt)
CN (1)	CN1140525C (pt)
AP (1)	AP1396A (pt)
AR (1)	AR020294A1 (pt)
AT (1)	ATE234832T1 (pt)
AU (1)	AU775861B2 (pt)
BG (1)	BG106152A (pt)
BR (1)	BR0011284A (pt)
CA (1)	CA2374643C (pt)
CO (1)	CO5170464A1 (pt)
CR (1)	CR6503A (pt)
CZ (1)	CZ20014164A3 (pt)
DE (1)	DE60001736T2 (pt)
DK (1)	DK1178984T3 (pt)
DZ (1)	DZ3044A1 (pt)
EA (1)	EA004233B1 (pt)
EE (1)	EE04719B1 (pt)
ES (1)	ES2190781T3 (pt)
GC (1)	GC0000254A (pt)
GE (1)	GEP20043225B (pt)
GT (1)	GT200000073A (pt)
HK (1)	HK1046280B (pt)
HN (1)	HN2000000057A (pt)
HR (1)	HRP20010861A2 (pt)
HU (1)	HUP0201443A3 (pt)
IL (1)	IL145949A0 (pt)
IS (1)	IS6123A (pt)
MA (1)	MA26734A1 (pt)
MX (1)	MXPA01011977A (pt)
MY (1)	MY123373A (pt)
NO (1)	NO322496B1 (pt)
NZ (1)	NZ514698A (pt)
OA (1)	OA11944A (pt)
PA (1)	PA8495201A1 (pt)
PE (1)	PE20010165A1 (pt)
PL (1)	PL198658B1 (pt)
PT (1)	PT1178984E (pt)
SK (1)	SK285819B6 (pt)
SV (1)	SV2002000077A (pt)
TN (1)	TNSN00105A1 (pt)
TR (1)	TR200103332T2 (pt)
TW (1)	TWI275588B (pt)
UA (1)	UA71004C2 (pt)
UY (1)	UY26147A1 (pt)
WO (1)	WO2000071538A2 (pt)
ZA (1)	ZA200109554B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW426667B (en) *	1997-11-19	2001-03-21	Pfizer	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
EP1095939B1 (en) *	1999-10-18	2004-01-07	Pfizer Products Inc.	Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
DE10311984A1 (de) *	2003-03-12	2004-09-23	Freie Universität Berlin	Verwendung von NEP-assoziierten Molekülen zur Behandlung von nichtimmunogenen-nichthypertensiven Zivilisationskrankheiten
US7122700B2 (en) *	2004-07-30	2006-10-17	Xerox Corporation	Arylamine processes
US7868016B2 (en) *	2005-07-13	2011-01-11	Baxter International Inc.	Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
WO2009109001A1 (en) *	2008-03-04	2009-09-11	Adelaide Research & Innovation Pty Ltd	Method for preventing and/or treating a disease, condition or state associated with reduced dopaminergic neuron function
EP2307397B1 (en)	2008-06-25	2014-08-20	Array Biopharma, Inc.	6-substituted phenoxychroman carboxylic acid derivatives
CN117343036A (zh) *	2023-03-20	2024-01-05	江苏联环药业股份有限公司	异苯并二氢吡喃类化合物及其药物组合物和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY110227A (en) *	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
GB9317987D0 (en) *	1993-08-26	1993-10-13	Glaxo Group Ltd	Chemical compounds
CA2216701A1 (en) *	1995-03-27	1996-10-03	Akira Okayama	Piperidine derivatives
TW475930B (en) *	1995-04-24	2002-02-11	Novartis Ag	Novel compound, its use and pharmaceutical composition comprising it
ES2155601T3 (es) *	1995-07-07	2001-05-16	Pfizer	Compuestos de benzolactama sustituidos como antagonistas de la sustancia p.
TW340842B (en) *	1995-08-24	1998-09-21	Pfizer	Substituted benzylaminopiperidine compounds
TW426667B (en) *	1997-11-19	2001-03-21	Pfizer	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists

2000
- 2000-04-20 IL IL14594900A patent/IL145949A0/xx unknown
- 2000-04-20 AU AU36673/00A patent/AU775861B2/en not_active Ceased
- 2000-04-20 CN CNB008078750A patent/CN1140525C/zh not_active Expired - Fee Related
- 2000-04-20 WO PCT/IB2000/000493 patent/WO2000071538A2/en active IP Right Grant
- 2000-04-20 CA CA002374643A patent/CA2374643C/en not_active Expired - Fee Related
- 2000-04-20 NZ NZ514698A patent/NZ514698A/en unknown
- 2000-04-20 PL PL352409A patent/PL198658B1/pl unknown
- 2000-04-20 TR TR2001/03332T patent/TR200103332T2/xx unknown
- 2000-04-20 DE DE60001736T patent/DE60001736T2/de not_active Expired - Fee Related
- 2000-04-20 ES ES00915314T patent/ES2190781T3/es not_active Expired - Lifetime
- 2000-04-20 AP APAP/P/2001/002327A patent/AP1396A/en active
- 2000-04-20 GE GEAP20006203A patent/GEP20043225B/en unknown
- 2000-04-20 HU HU0201443A patent/HUP0201443A3/hu unknown
- 2000-04-20 SK SK1659-2001A patent/SK285819B6/sk not_active IP Right Cessation
- 2000-04-20 CZ CZ20014164A patent/CZ20014164A3/cs unknown
- 2000-04-20 MX MXPA01011977A patent/MXPA01011977A/es unknown
- 2000-04-20 PT PT00915314T patent/PT1178984E/pt unknown
- 2000-04-20 EE EEP200100612A patent/EE04719B1/xx not_active IP Right Cessation
- 2000-04-20 EA EA200101109A patent/EA004233B1/ru not_active IP Right Cessation
- 2000-04-20 AT AT00915314T patent/ATE234832T1/de not_active IP Right Cessation
- 2000-04-20 UA UA2001117936A patent/UA71004C2/uk unknown
- 2000-04-20 EP EP00915314A patent/EP1178984B1/en not_active Expired - Lifetime
- 2000-04-20 KR KR10-2001-7014803A patent/KR100453301B1/ko not_active IP Right Cessation
- 2000-04-20 JP JP2000619795A patent/JP3802762B2/ja not_active Expired - Fee Related
- 2000-04-20 BR BR0011284-4A patent/BR0011284A/pt not_active Application Discontinuation
- 2000-04-20 DK DK00915314T patent/DK1178984T3/da active
- 2000-04-24 OA OA1200100302A patent/OA11944A/en unknown
- 2000-04-25 HN HN2000000057A patent/HN2000000057A/es unknown
- 2000-05-05 PA PA20008495201A patent/PA8495201A1/es unknown
- 2000-05-10 CO CO00033397A patent/CO5170464A1/es not_active Application Discontinuation
- 2000-05-16 TW TW089109370A patent/TWI275588B/zh not_active IP Right Cessation
- 2000-05-17 US US09/572,213 patent/US6239147B1/en not_active Expired - Fee Related
- 2000-05-17 MA MA25978A patent/MA26734A1/fr unknown
- 2000-05-17 TN TNTNSN00105A patent/TNSN00105A1/fr unknown
- 2000-05-17 DZ DZ000087A patent/DZ3044A1/xx active
- 2000-05-18 GT GT200000073A patent/GT200000073A/es unknown
- 2000-05-18 UY UY26147D patent/UY26147A1/es unknown
- 2000-05-19 MY MYPI20002220A patent/MY123373A/en unknown
- 2000-05-19 SV SV2000000077A patent/SV2002000077A/es not_active Application Discontinuation
- 2000-05-19 PE PE2000000472A patent/PE20010165A1/es not_active Application Discontinuation
- 2000-05-19 AR ARP000102386A patent/AR020294A1/es active IP Right Grant
- 2000-05-21 GC GCP2000665 patent/GC0000254A/en active
2001
- 2001-10-23 IS IS6123A patent/IS6123A/is unknown
- 2001-11-19 CR CR6503A patent/CR6503A/es unknown
- 2001-11-20 ZA ZA200109554A patent/ZA200109554B/en unknown
- 2001-11-20 NO NO20015652A patent/NO322496B1/no unknown
- 2001-11-20 HR HR20010861A patent/HRP20010861A2/hr not_active Application Discontinuation
- 2001-11-26 BG BG106152A patent/BG106152A/xx unknown
2002
- 2002-10-30 HK HK02107866.4A patent/HK1046280B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE60001736T2 (de)	2003-09-18
NO20015652D0 (no)	2001-11-20
PT1178984E (pt)	2003-06-30
CA2374643A1 (en)	2000-11-30
SK285819B6 (sk)	2007-09-06
IS6123A (is)	2001-10-23
DK1178984T3 (da)	2003-06-10
UA71004C2 (uk)	2004-11-15
HK1046280B (zh)	2004-10-21
PL198658B1 (pl)	2008-07-31
TWI275588B (en)	2007-03-11
CO5170464A1 (es)	2002-06-27
CN1355799A (zh)	2002-06-26
SV2002000077A (es)	2002-07-03
HRP20010861A2 (en)	2003-04-30
MY123373A (en)	2006-05-31
TR200103332T2 (tr)	2002-04-22
AU775861B2 (en)	2004-08-19
NZ514698A (en)	2005-01-28
EA004233B1 (ru)	2004-02-26
JP3802762B2 (ja)	2006-07-26
GEP20043225B (en)	2004-04-26
EP1178984B1 (en)	2003-03-19
PE20010165A1 (es)	2001-02-20
AP2001002327A0 (en)	2001-12-31
NO322496B1 (no)	2006-10-16
CN1140525C (zh)	2004-03-03
IL145949A0 (en)	2002-07-25
MXPA01011977A (es)	2002-05-06
TNSN00105A1 (fr)	2005-11-10
BR0011284A (pt)	2002-03-05
ES2190781T3 (es)	2003-08-16
HN2000000057A (es)	2001-03-02
EE04719B1 (et)	2006-10-16
EP1178984A2 (en)	2002-02-13
ZA200109554B (en)	2002-11-20
US6239147B1 (en)	2001-05-29
HK1046280A1 (en)	2003-01-03
BG106152A (en)	2002-06-28
MA26734A1 (fr)	2004-12-20
KR100453301B1 (ko)	2004-10-20
PL352409A1 (en)	2003-08-25
UY26147A1 (es)	2000-12-29
CZ20014164A3 (cs)	2003-01-15
GC0000254A (en)	2006-11-01
WO2000071538A2 (en)	2000-11-30
WO2000071538A3 (en)	2001-02-22
HUP0201443A3 (en)	2005-09-28
CR6503A (es)	2004-02-03
NO20015652L (no)	2002-01-14
DE60001736D1 (de)	2003-04-24
GT200000073A (es)	2001-11-09
ATE234832T1 (de)	2003-04-15
EE200100612A (et)	2003-02-17
SK16592001A3 (sk)	2003-03-04
AR020294A1 (es)	2002-05-02
HUP0201443A2 (en)	2002-08-28
PA8495201A1 (es)	2002-08-26
KR20020016793A (ko)	2002-03-06
EA200101109A1 (ru)	2002-04-25
AU3667300A (en)	2000-12-12
DZ3044A1 (fr)	2004-03-27
AP1396A (en)	2005-04-19
CA2374643C (en)	2006-02-14
JP2003500405A (ja)	2003-01-07

Publication	Publication Date	Title
AU734218B2 (en)	2001-06-07	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
Vlahova et al.	1989	Synthesis of galanthamine and related alkaloids-new approaches. I.
OA11944A (en)	2006-04-12	1-Trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives.
US20030105124A1 (en)	2003-06-05	Substituted benzolactam compounds
US4806655A (en)	1989-02-21	Process for the stereospecific synthesis of indole derivatives
Ando et al.	1982	Chemistry of chiral vitamin B6 analogs. IV. Syntheses of chiral pyridoxal and pyridoxamine analogs having a branched" ansa chain" between 2'-and 5'-positions.
EP1175417B1 (en)	2004-01-07	Substituted benzolactam compounds
FR2479194A1 (fr)	1981-10-02	Nouveau derive d'alcool benzylique, procede pour le preparer et application a des compositions pharmaceutiques
CN112624953A (zh)	2021-04-09	胆绿素或其衍生物的制备方法
MXPA00004889A (en)	2001-07-09	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists